nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—SLC22A6—Furosemide—dilated cardiomyopathy	0.188	1	CbGbCtD
Meclofenamic acid—Unspecified visual loss—Lisinopril—dilated cardiomyopathy	0.0393	0.0864	CcSEcCtD
Meclofenamic acid—KCNQ2—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0384	0.107	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0384	0.107	CbGpPWpGaD
Meclofenamic acid—Ulcer—Spironolactone—dilated cardiomyopathy	0.0222	0.0488	CcSEcCtD
Meclofenamic acid—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX1—dilated cardiomyopathy	0.0217	0.0608	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0188	0.0526	CbGpPWpGaD
Meclofenamic acid—Blindness—Lisinopril—dilated cardiomyopathy	0.0155	0.0341	CcSEcCtD
Meclofenamic acid—KCNQ2—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.0147	0.0411	CbGpPWpGaD
Meclofenamic acid—KCNQ3—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.0147	0.0411	CbGpPWpGaD
Meclofenamic acid—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.013	0.0287	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.013	0.0286	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0116	0.0256	CcSEcCtD
Meclofenamic acid—Renal failure—Spironolactone—dilated cardiomyopathy	0.0115	0.0254	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.011	0.0241	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00997	0.0219	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00976	0.0215	CcSEcCtD
Meclofenamic acid—Alopecia—Spironolactone—dilated cardiomyopathy	0.00932	0.0205	CcSEcCtD
Meclofenamic acid—KCNQ3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00926	0.0259	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00926	0.0259	CbGpPWpGaD
Meclofenamic acid—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00919	0.0202	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00879	0.0193	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00852	0.0187	CcSEcCtD
Meclofenamic acid—Malaise—Spironolactone—dilated cardiomyopathy	0.00828	0.0182	CcSEcCtD
Meclofenamic acid—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00822	0.0181	CcSEcCtD
Meclofenamic acid—Discomfort—Spironolactone—dilated cardiomyopathy	0.00772	0.017	CcSEcCtD
Meclofenamic acid—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.00748	0.0209	CbGpPWpGaD
Meclofenamic acid—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0071	0.0156	CcSEcCtD
Meclofenamic acid—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00689	0.0152	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00647	0.0142	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00634	0.0139	CcSEcCtD
Meclofenamic acid—Renal failure—Furosemide—dilated cardiomyopathy	0.00628	0.0138	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00617	0.0136	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00596	0.0131	CcSEcCtD
Meclofenamic acid—Urticaria—Spironolactone—dilated cardiomyopathy	0.00595	0.0131	CcSEcCtD
Meclofenamic acid—KCNQ2—Axon guidance—SCN5A—dilated cardiomyopathy	0.00556	0.0155	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—SCN5A—dilated cardiomyopathy	0.00556	0.0155	CbGpPWpGaD
Meclofenamic acid—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00542	0.0119	CcSEcCtD
Meclofenamic acid—Tinnitus—Furosemide—dilated cardiomyopathy	0.00535	0.0118	CcSEcCtD
Meclofenamic acid—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00532	0.0117	CcSEcCtD
Meclofenamic acid—Pruritus—Spironolactone—dilated cardiomyopathy	0.0053	0.0117	CcSEcCtD
Meclofenamic acid—KCNQ3—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00524	0.0146	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00524	0.0146	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00513	0.0113	CcSEcCtD
Meclofenamic acid—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00503	0.0111	CcSEcCtD
Meclofenamic acid—Vomiting—Spironolactone—dilated cardiomyopathy	0.00476	0.0105	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00475	0.0105	CcSEcCtD
Meclofenamic acid—Renal failure—Lisinopril—dilated cardiomyopathy	0.00471	0.0104	CcSEcCtD
Meclofenamic acid—Vision blurred—Furosemide—dilated cardiomyopathy	0.00471	0.0104	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00447	0.00985	CcSEcCtD
Meclofenamic acid—Leukopenia—Furosemide—dilated cardiomyopathy	0.00447	0.00984	CcSEcCtD
Meclofenamic acid—Nausea—Spironolactone—dilated cardiomyopathy	0.00445	0.00979	CcSEcCtD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.0041	0.0115	CbGpPWpGaD
Meclofenamic acid—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00407	0.00895	CcSEcCtD
Meclofenamic acid—KCNQ3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00404	0.0113	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00404	0.0113	CbGpPWpGaD
Meclofenamic acid—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00401	0.00883	CcSEcCtD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00399	0.0111	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00397	0.0111	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00397	0.0111	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00397	0.0111	CbGpPWpGaD
Meclofenamic acid—Anorexia—Furosemide—dilated cardiomyopathy	0.00389	0.00855	CcSEcCtD
Meclofenamic acid—KCNQ2—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00388	0.0108	CbGpPWpGaD
Meclofenamic acid—KCNQ3—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00388	0.0108	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00387	0.0108	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00387	0.0108	CbGpPWpGaD
Meclofenamic acid—Alopecia—Lisinopril—dilated cardiomyopathy	0.0038	0.00837	CcSEcCtD
Meclofenamic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00377	0.0105	CbGpPWpGaD
Meclofenamic acid—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00366	0.00805	CcSEcCtD
Meclofenamic acid—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00354	0.0078	CcSEcCtD
Meclofenamic acid—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00353	0.00777	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00352	0.00774	CcSEcCtD
Meclofenamic acid—Fatigue—Furosemide—dilated cardiomyopathy	0.00351	0.00773	CcSEcCtD
Meclofenamic acid—Constipation—Furosemide—dilated cardiomyopathy	0.00349	0.00767	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00348	0.00765	CcSEcCtD
Meclofenamic acid—Malaise—Lisinopril—dilated cardiomyopathy	0.00338	0.00743	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00336	0.00739	CcSEcCtD
Meclofenamic acid—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00335	0.00738	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00333	0.00733	CcSEcCtD
Meclofenamic acid—Palpitations—Lisinopril—dilated cardiomyopathy	0.00331	0.00729	CcSEcCtD
Meclofenamic acid—Urticaria—Furosemide—dilated cardiomyopathy	0.00324	0.00712	CcSEcCtD
Meclofenamic acid—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00322	0.00709	CcSEcCtD
Meclofenamic acid—Discomfort—Lisinopril—dilated cardiomyopathy	0.00315	0.00693	CcSEcCtD
Meclofenamic acid—KCNQ3—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00312	0.00872	CbGpPWpGaD
Meclofenamic acid—KCNQ2—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00312	0.00872	CbGpPWpGaD
Meclofenamic acid—Oedema—Lisinopril—dilated cardiomyopathy	0.00306	0.00673	CcSEcCtD
Meclofenamic acid—Asthenia—Furosemide—dilated cardiomyopathy	0.00292	0.00643	CcSEcCtD
Meclofenamic acid—Anorexia—Lisinopril—dilated cardiomyopathy	0.00292	0.00641	CcSEcCtD
Meclofenamic acid—Pruritus—Furosemide—dilated cardiomyopathy	0.00288	0.00634	CcSEcCtD
Meclofenamic acid—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00279	0.00614	CcSEcCtD
Meclofenamic acid—Insomnia—Lisinopril—dilated cardiomyopathy	0.00277	0.00609	CcSEcCtD
Meclofenamic acid—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00275	0.00604	CcSEcCtD
Meclofenamic acid—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00273	0.00763	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00266	0.00743	CbGpPWpGaD
Meclofenamic acid—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00266	0.00585	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00264	0.00581	CcSEcCtD
Meclofenamic acid—Fatigue—Lisinopril—dilated cardiomyopathy	0.00264	0.0058	CcSEcCtD
Meclofenamic acid—Constipation—Lisinopril—dilated cardiomyopathy	0.00262	0.00575	CcSEcCtD
Meclofenamic acid—Vomiting—Furosemide—dilated cardiomyopathy	0.00259	0.0057	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00254	0.00709	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00252	0.00554	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0025	0.0055	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00247	0.00689	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00246	0.00687	CbGpPWpGaD
Meclofenamic acid—Urticaria—Lisinopril—dilated cardiomyopathy	0.00243	0.00535	CcSEcCtD
Meclofenamic acid—Nausea—Furosemide—dilated cardiomyopathy	0.00242	0.00533	CcSEcCtD
Meclofenamic acid—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00242	0.00532	CcSEcCtD
Meclofenamic acid—KCNQ3—Axon guidance—PSEN2—dilated cardiomyopathy	0.00235	0.00655	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—PSEN2—dilated cardiomyopathy	0.00235	0.00655	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00232	0.00648	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00231	0.00646	CbGpPWpGaD
Meclofenamic acid—Asthenia—Lisinopril—dilated cardiomyopathy	0.00219	0.00483	CcSEcCtD
Meclofenamic acid—Pruritus—Lisinopril—dilated cardiomyopathy	0.00216	0.00476	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00214	0.00598	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00209	0.0046	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00208	0.00582	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00208	0.00582	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.00206	0.00576	CbGpPWpGaD
Meclofenamic acid—Vomiting—Lisinopril—dilated cardiomyopathy	0.00194	0.00428	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00194	0.00541	CbGpPWpGaD
Meclofenamic acid—Nausea—Lisinopril—dilated cardiomyopathy	0.00182	0.004	CcSEcCtD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00173	0.00483	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00171	0.00479	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00167	0.00468	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00167	0.00468	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00149	0.00416	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—ITGB1—dilated cardiomyopathy	0.00147	0.0041	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—ITGB1—dilated cardiomyopathy	0.00147	0.0041	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00143	0.00399	CbGpPWpGaD
Meclofenamic acid—KCNQ2—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00142	0.00397	CbGpPWpGaD
Meclofenamic acid—KCNQ3—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00142	0.00397	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00141	0.00394	CbGpPWpGaD
Meclofenamic acid—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00137	0.00384	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00133	0.00372	CbGpPWpGaD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00118	0.00331	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—RAC1—dilated cardiomyopathy	0.00118	0.0033	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—RAC1—dilated cardiomyopathy	0.00118	0.0033	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00115	0.00322	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00112	0.00313	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.0011	0.00307	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ANKRD1—dilated cardiomyopathy	0.0011	0.00307	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00109	0.00306	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00107	0.00299	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00105	0.00293	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00105	0.00293	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—TAZ—dilated cardiomyopathy	0.00103	0.00289	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—TAZ—dilated cardiomyopathy	0.00103	0.00288	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00101	0.00282	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00101	0.00281	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SDHA—dilated cardiomyopathy	0.000934	0.00261	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SDHA—dilated cardiomyopathy	0.000931	0.0026	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000915	0.00256	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000896	0.0025	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—CD36—dilated cardiomyopathy	0.000893	0.0025	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—CD36—dilated cardiomyopathy	0.000893	0.0025	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000893	0.00249	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—RAF1—dilated cardiomyopathy	0.000881	0.00246	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—RAF1—dilated cardiomyopathy	0.000881	0.00246	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000873	0.00244	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000871	0.00243	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000871	0.00243	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000849	0.00237	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—RAC1—dilated cardiomyopathy	0.000842	0.00235	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—RAC1—dilated cardiomyopathy	0.000842	0.00235	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000832	0.00232	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00081	0.00226	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000798	0.00223	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—RAF1—dilated cardiomyopathy	0.000782	0.00219	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—RAF1—dilated cardiomyopathy	0.000782	0.00219	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000634	0.00177	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000612	0.00171	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000583	0.00163	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00057	0.00159	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NPPA—dilated cardiomyopathy	0.000569	0.00159	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000568	0.00159	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—RAF1—dilated cardiomyopathy	0.000558	0.00156	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—RAF1—dilated cardiomyopathy	0.000558	0.00156	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000555	0.00155	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000553	0.00154	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PSEN2—dilated cardiomyopathy	0.000551	0.00154	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000545	0.00152	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—EGFR—dilated cardiomyopathy	0.000536	0.0015	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—EGFR—dilated cardiomyopathy	0.000536	0.0015	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.0005	0.0014	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000498	0.00139	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000476	0.00133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000456	0.00127	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000448	0.00125	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00044	0.00123	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000437	0.00122	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000431	0.0012	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000422	0.00118	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000405	0.00113	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000386	0.00108	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—EGFR—dilated cardiomyopathy	0.000383	0.00107	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—EGFR—dilated cardiomyopathy	0.000383	0.00107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000378	0.00106	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—TNF—dilated cardiomyopathy	0.000364	0.00102	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—TNF—dilated cardiomyopathy	0.000364	0.00102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.000356	0.000994	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000347	0.00097	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000343	0.000957	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000343	0.000957	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.000322	0.000899	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000318	0.00089	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000308	0.000862	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000288	0.000805	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000286	0.000799	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RAC1—dilated cardiomyopathy	0.000277	0.000774	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000274	0.000767	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000263	0.000736	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	0.000254	0.000709	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GPX1—dilated cardiomyopathy	0.000253	0.000706	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00025	0.000698	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CD36—dilated cardiomyopathy	0.000247	0.000691	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000247	0.00069	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CD36—dilated cardiomyopathy	0.000246	0.000688	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000241	0.000672	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AGT—dilated cardiomyopathy	0.000223	0.000622	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AGT—dilated cardiomyopathy	0.000222	0.000619	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000217	0.000605	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000215	0.0006	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NPPA—dilated cardiomyopathy	0.000197	0.000549	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000196	0.000548	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000196	0.000548	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000194	0.000542	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000191	0.000534	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PSEN2—dilated cardiomyopathy	0.00019	0.000532	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000187	0.000522	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000185	0.000518	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RAF1—dilated cardiomyopathy	0.000184	0.000513	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000177	0.000494	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000172	0.000481	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000129	0.000359	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—dilated cardiomyopathy	0.000126	0.000352	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.00011	0.000307	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000107	0.000299	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AGT—dilated cardiomyopathy	9.65e-05	0.00027	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RAC1—dilated cardiomyopathy	9.57e-05	0.000268	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—dilated cardiomyopathy	8.82e-05	0.000247	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	8.74e-05	0.000244	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CD36—dilated cardiomyopathy	8.51e-05	0.000238	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AGT—dilated cardiomyopathy	7.66e-05	0.000214	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RAF1—dilated cardiomyopathy	6.35e-05	0.000177	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—dilated cardiomyopathy	4.35e-05	0.000122	CbGpPWpGaD
